All news from Anaesthesiology

Mepolizumab for Eosinophilic COPD

There has been a lot of interest in biologics, which are focused on the cytokines that modify eosinophil biology in asthma. We have seen a number of studies in the past 2 years and the approval of molecules that target the eosinophilic phenotype in asthma.

New laser scanners: eye disease before vision loss occurs

SFU engineering science professor Marinko Sarunic has developed a high resolution retinal imaging scanner that will one day revolutionize eye care, helping ophthalmologists diagnose eye diseases before vision loss occurs. The retina is the light-sensitive tissue at the back of the eye. Its 100 million photoreceptors convert light into the images that our brain 'sees.'

Dengue Virus Blocker: Field trials outperformed lab experiments

The history of medicine is filled with treatments and vaccines that worked beautifully under test conditions in the lab but failed for unexpected reasons when put out to wider trial. So it's a bit of a shock when something actually works better in the “real world” than in the laboratory, but that's what happened when a dengue fever prevention mechanism got tested in Vietnam.

Building Resilience in Adolescents with Cancer

A brief in-person intervention that only requires four counseling sessions appears to improve psychosocial health among adolescents and young adults living with cancer. The intervention, called Promoting Resilience in Stress Management (PRISM), improved resilience and quality of life, increased hope, and lowered distress in the majority of patients. The study was presented at Palliative Care in Oncology Symposium (PCOS) 2017 in San Diego, California.

High Blood Pressure Drug Prolongs Life Span in Roundworms

An FDA-approved drug to treat high blood pressure seems to extend lifespan in worms via a cell signaling pathway that may mimic caloric restriction, according to the study published in the journal Nature CommunicationsThe drug, hydralazine, extended lifespan about 25% in two strains of C. elegans (roundworms), one a wild-type and the other bred to generate high levels of a neurotoxic protein called tau that in humans is associated with Alzheimer's disease.

Cancer cells can be killed: Fluorescent nanomedicine, Study approaches

Scientists have established a nanomedicine platform for cancer that can help doctors know which tissue to cut out as well as kill any malignant cells that can't be surgically removed. Oregon State University scientists have developed a nanomedicine platform for cancer that can help doctors know which tissue to cut out as well as kill any malignant cells that can't be surgically removed. The platform allows for greater precision and thoroughness in cancer treatment. This study was published in Theranostics.

Increased Risk of Skin Cancer can cause from Common Blood Pressure Drug

According to Danish study, People who take a certain diuretic prescribed to control fluid retention and treat high blood pressure may be more likely to get skin cancer than other individuals. While the drug, hydrochlorothiazide, has long been linked to an increased risk of sunburns, the current study offers fresh evidence that this commonly prescribed medication may also make people more likely to develop basal cell carcinoma and squamous cell carcinoma. This study has published in Journal of the American Academy of Dermatology.